Beliefs related to oral antidiabetic use among individuals with diabetes

Abstract

Objective: To identify beliefs related to oral antidiabetic use among individuals with type 2 diabetes mellitus, based on the Theory of Planned Behavior. Method: This is a descriptive, quantitative and qualitative study conducted with 32 participants using oral antidiabetic drugs. Data was collected through an open question tool and analyzed by number of emissions and content. Results: Among the behavioral beliefs, the following stand out: (a) as an advantage, to keep diabetes controlled; and (b) as disadvantages, gastric pain and discomfort, nausea and diarrhea. In the normative beliefs, family stood out as a social referent (children, mother and siblings). As for the control beliefs, taking the tablets with water and the size of the tablets stood out as practicalities and difficulties, respectively, in relation to the oral therapy follow-up. Conclusion and implications for practice: It was possible to identify the beliefs regarding the behavior of taking oral antidiabetics that will contribute to foster educational strategies with the potential to strengthen the positive beliefs and to revert the negative ones, in favor of adherence to drug therapy, glycemic control and quality of life.

Barriers and facilitators to successful management of type 2 diabetes mellitus in Latin America and the Caribbean: A systematic review

“…Four themes on how “social influences” affect diabetes management were identified in 40 studies (66.7%) [ 27 – 29 , 31 , 32 , 35 , 37 , 39 – 47 , 49 , 51 – 53 , 57 , 59 – 62 , 64 – 67 , 70 , 73 – 77 , 79 , 81 , 83 – 85 ]: lack of and support from family and friends, social gatherings, stigma and peer support. More than half of the studies described that family and friends’ support is a fundamental piece in the management of the disease.…”

“…Along a similar line, regarding “beliefs about capabilities ” 6 studies identified issues with patients not feeling capable of controlling the disease, for example, not being able to inject insulin correctly [ 27 , 32 , 65 , 77 , 78 , 86 ]. The domain “memory , attention , and decision processes” was applied in 8 studies [ 27 , 33 , 37 , 43 , 47 , 62 , 82 , 86 ], and “intentions” (4 studies) [ 31 , 47 , 53 , 80 , 82 , 85 ].…”

Determinants of medication adherence among Iranian patients with type 2 diabetes: An application of health action process approach

“…Guénette and et al., presented adherence to medication associated with having signs to remember to take them [ 39 ], Gouveia also reported that forgetting to take medication in patient with type 2 diabetes was not a barrier of adherence because it was perceived as an unaware behavior by patients; however, if this behavior was repeated it could be on purpose. At this stage, patient paid little attention to take their medications [ 40 ]. Most of the patients had taken their anti-diabetic medicines the previous day.…”